Year archive

BLINKLAB LIMITED — 2026 filings

All 26 regulatory filings released by BLINKLAB LIMITED (BB1) in 2026, sourced directly from the official regulator.

26 Filings

2026 Period

2026 filings (26)

Filing	Released	Lang
Notice of General Meeting & Proxy Form 38 pages 690.8KB Proxy Solicitation & Information Statement	2026-05-21	English
Letter to Shareholders & Proxy Form 3 pages 301.4KB Proxy Solicitation & Information Statement	2026-05-21	English
Therapy Evaluation for Neurodevelopmental Conditions 3 pages 241.0KB Regulatory Filings	2026-05-18	English
BB1 to present at Stocks in the Vines Investor Access Day 2 pages 277.5KB Regulatory Filings	2026-05-13	English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 559.4KB Interim / Quarterly Report	2026-04-29	English
Application for quotation of securities - BB1 6 pages 18.5KB Share Issue/Capital Change	2026-04-22	English
Section 708A Notice 1 page 203.4KB Share Issue/Capital Change	2026-04-22	English
BlinkLab Invited to Present at Ignite Investment Summits 30 pages 11.9MB Investor Presentation	2026-04-16	English
BlinkLab Secures A$17.5M to Launch Autism Diagnostic Aid 5 pages 237.9KB Share Issue/Capital Change	2026-04-15	English
Proposed issue of securities - BB1 6 pages 22.3KB Share Issue/Capital Change	2026-04-15	English
Update - Proposed issue of securities - BB1 6 pages 22.5KB Share Issue/Capital Change	2026-04-15	English
Trading Halt 2 pages 208.4KB Capital/Financing Update	2026-04-13	English
Application for quotation of securities - BB1 5 pages 16.6KB Share Issue/Capital Change	2026-04-06	English
Notice of Release of Escrowed Securities 1 page 241 Capital/Financing Update	2026-03-25	English
Validation Program Commences-FDA 510(k) - First Participant 3 pages 404.1KB Regulatory Filings	2026-03-23	English
Morocco's Nationwide Government-Funded Autism Screening 6 pages 342.1KB Capital/Financing Update	2026-03-22	English
Trading Halt 2 pages 317.6KB Regulatory Filings	2026-03-18	English
Clinical Trial Network for Pivotal FDA Study Complete 5 pages 430.7KB Regulatory Filings	2026-03-15	English
BlinkLab Forms Partnership with SHANK2 Autism Foundation 3 pages 238.3KB Regulatory Filings	2026-03-12	English
Half Yearly Report and Accounts 22 pages 668.0KB Interim / Quarterly Report	2026-02-24	English
Notification regarding unquoted securities - BB1 6 pages 18.9KB Share Issue/Capital Change	2026-02-12	English
BB1 Expands Pivotal FDA Trial Network to Nine Elite Sites 5 pages 424.1KB Regulatory Filings	2026-02-11	English
Quarterly Activities/Appendix 4C Cash Flow Report 12 pages 623.8KB Interim / Quarterly Report	2026-01-29	English
BB1 Presents at Simons Foundation Autism Research Initiative 3 pages 323.4KB Regulatory Filings	2026-01-22	English
BlinkLab Receives $822k R&D Tax Incentive Refund 2 pages 199.9KB Capital/Financing Update	2026-01-07	English
High-Profile Journal Publication Validates BB1 Technology 4 pages 290.2KB Regulatory Filings	2026-01-04	English